Patient-reported outcomes in patients with PIK3CA-mutated HR+, HER 2–negative advanced breast cancer from SOLAR-1 March 29, 2021
Pyrotinib plus capecitabine vs lapatinib plus capecitabine for the treatment of HER2+ metastatic breast cancer February 17, 2021